

Shared by @JAMA_current ↗
Shared by @WebMD ↗
Shared by @DrAndyGalpin ↗

This case report describes 2 patients with lichen sclerosus whose symptoms improved with glucagon-like peptide-1 receptor agonists.
This review from the US National Psoriasis Foundation Medical Board provides an evidence-informed narrative synthesis and practical considerations to introduce dermatologists to glucagon-like peptide-1 receptor agonists for treatment of psoriasis with met


